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Abstract
This purpose of this study was to evaluate the effects of four weeks of magnesiumcreatine chelate (MgCr), alkaline creatine (AlkCr), and placebo (P) on delayed onset muscle
soreness (DOMS). Subjects were 36 young (18-24 years old), healthy, recreationally active
individuals, randomly assigned to groups. Double blind supplementation was dextran (P), 5 g
creatine, 400 mg (MgCr), and 5 g creatine plus soda ash (AlkCr) per day. Subjects exercised
on an eccentric training machine with foot pedals yielding force that was resisted
eccentrically. Peak eccentric force was obtained at 35 cycles per minute. Subjects maintained
65% of the peak eccentric force, for five minutes of continuous work. They reported muscle
soreness scores corresponding to a visual analog scale with scores from 1, normal, to 10,
very, very sore at 12, 24, 48, 60, and 72 hours post exercise. Repeated measures ANOVA
was applied. The creatine groups did have significant main effects of time in DOMS on a
visual analog scale after 5 minutes of eccentric exercise (p<0.05). There were no significant
effects between creatine groups (p<0.05). Within group time effects were observed at 12, 24,
and 36 hour intervals for AlkCr and at 12 hour intervals up to the 60 hours for MgCr, with
DOMS scores lower following intervention. Pre intervention 12- and 72-hour soreness scores
were P: 6.0±1.6, 3.6±2.3; MgCr: 5.0±2.9, 3.5±2.3; AlkCr: 4.5±1.9, 3.9±1.9 and post
intervention 12- and 72-hour soreness scores were P: 4.7±1.5, 2.7±1.2; MgCr: 3.2±1.6,
2.3±1.6; AlkCr: 3.5±2.0, 2.5±1.9. Creatine supplementation regimens for four weeks
ameliorated DOMS perception following 5-minutes of eccentric activity. The mechanism for
the findings remains to be elucidated, but may be related to anti-inflammatory effects.

	
  

iv	
  

Acknowledgements
I would like to thank the faculty and staff of Western Washington University’s
Physical Education, Health, and Recreation department for their support and guidance over
the last four years. I would especially like to thank the members of my thesis committee, Dr.
Lorrie Brilla, Dr. Dave Suprak, and Dr. Kathleen Knutzen for their help and support along
the way.

	
  

v	
  

Table of Contents
Abstract ………………………………………………………..……………

iv

Acknowledgments …………………………………………………………..

v

List of Tables ………………………………………………………………..

viii

List of Figures ………………………………………………………………

ix

List of Appendices …………………………………………………….........

x

CHAPTER I THE PROBLEM AND ITS SCOPE
Purpose ...........................…………………………………………………......

2

Experimental Hypothesis …………………………………………………….

2

Significance of the Study …………………………………………………….

2

Limitations of the Study……………………………………………………...

3

Definitions ………………………………………………………..…………..

4

CHAPTER II REVIEW OF THE LITERATURE
Introduction …………………………………………………………………..

5

Eccentric Muscle Action ……………………………………………………..

5

Exercise-Induced Muscle Injury and DOMS………………………………....

8

Role of Creatine………………………………………………………………

13

Effects of Creatine Supplementation on Strength……………………………

16

Role of Magnesium………………………………………………………….

20

Effect of Magnesium Supplementation on Strength…………………………

22

Effects of Creatine and Magnesium on Fatigue……………………………..

24

Summary …………………………………………………………………….

26

CHAPTER III METHODS
Description of Study Population ……………………………………………
	
  

vi	
  

27

Design of Study …………………………………………………………….

28

Data Collection Procedures …………………………………………………

28

CHAPTER IV RESULTS AND DISCUSSION
Introduction ………………………………………………………………..

31

Subject Characteristics …………………………………………………….

31

Results ……………………………………………………………………..

32

Discussion ………………………………………………………………….

35

Summary ………………………………………………………………….

36

CHAPTER V SUMMARY AND CONCLUSIONS

	
  

Summary …………………………………………………………………..

37

Conclusions ………………………………………………………………..

38

Recommendations …………………………………………………………

38

References …………………………………………………………………

40

Appendices …………………………………………………………………

52-73

vii	
  

List of Tables
Table 1.

Subject Characteristics ……………………………………………...

32

Table 2.

DOMS reports after 5-Minute Bout of Eccentric Exercise....……….

33

	
  

viii	
  

List of Figures
Figure 1.

Delayed Onset Muscle Soreness Pre-Supplementation ……………..

33

Figure 2.

Delayed Onset Muscle Soreness Post-Supplementation …………….

34

Figure 3.

Creatine Effect on Delayed Onset Muscle Soreness …………………

34

	
  

ix	
  

List of Appendices

	
  

Appendix A.

Human Subjects Review Form and Responses…...............................

52

Appendix B.

Informed Consent …………………………………………………...

57

Appendix C. Visual Analog Scale …………………………………………………

60

x	
  

Chapter 1
The Problem and Its Scope
Introduction
The benefits of eccentric training have been widely researched and include greater
gains in strength, increased hypertrophy, lower metabolic demand and decreased motor unit
recruitment when compared to concentric training programs, thus establishing eccentric
muscle action as more efficient and effective (Babault, Pousson, Ballay, & Van Hoecke,
2001; LaStayo, Woolf, Lewek, Snyder-Mackler, Reich, & Lindstedt, 2003; Tesch, Dudley,
Duvoisin, Hather, & Harris, 2008). Eccentric muscle action is one of the primary causes of
exercise-induced muscle injury as evidenced by decreased maximum voluntary contraction
(MVC) force, increased concentrations of inflammatory markers and blood proteins,
increased passive muscle tension and increased severity of delay onset muscle soreness
(DOMS) post-exercise (Newham, McPhail, Mills, & Edwards, 1983). Creatine and
magnesium are both anti-inflammatory agents and may play a key role in decreasing the level
of DOMS, leading to improved training and performance outcomes for athletes and more
effective, more rapid recovery from exercise and less painful rehabilitation protocols (King
& Duffield, 2009; Rosene, Matthews, Ryan, Belmore, Bergsten, Balisdell, et al. 2009;
Santos, Bassit, Caperuto, & Costa Rosa, 2004; Selsby, DiSilvestro, & Devor, 2004).
Additionally, the lower metabolic cost of eccentric training results in less cardiovascular
stress, making eccentric training appealing to the elderly and individuals with cardiovascular
health issues. The severity of DOMS following high-intensity eccentric training limits many
individuals from reaping the benefits of eccentric training. More research on the attenuation

	
  

of DOMS will lead to better informed training and rehabilitation prescription for coaches,
trainers and physical therapists (Connolly, Sayers, & McHugh, 2003).
Purpose
The purpose of this study was to assess the effects of magnesium-creatine chelate,
alkaline creatine compound, and placebo supplementation on DOMS following eccentricallyinduced muscle damage. DOMS was induced using a device that required subjects to resist
loads at a rate relative to their maximum value. Study results may help clarify the effects of
magnesium-creatine chelate, alkaline creatine and placebo supplementation on exerciseinduced muscle soreness as measured using a visual analog scale. The results of this study
may also inform future research on nutritional supplementation and exercise prescription.
Null Hypothesis (H0)
The null hypothesis states that following high-intensity eccentric muscle action, there
will be no difference in DOMS as determined with a visual analog scale due to
supplementation of magnesium-creatine chelate, alkaline creatine compound, or placebo.
Significance of the Study
The ergogenic potential of creatine has been well-reviewed (Kreider, 2003). It has
been established that elevated muscle creatine levels improves muscle strength and augments
hypertrophy induced by strength training (Olsen, Aagaard, Kadi, Tufekovic, Verney et al.,
2006; Rawson & Volek, 2003). Recent studies show that creatine supplementation may result
in reduced inflammation, cell damage and pain following a high-intensity or exhaustive bout
of exercise (Bassit, Pineheiro, Vitzel, Spoesser, Silveira et al., 2010; Bassit, Curi, & Costa
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Rosa, 2008; Rawson et al., 2003; Rawson, Conti, & Miles, 2007; Santos, et al. 2004).
Magnesium plays a critical role in muscle function and attenuation of pain (Brilla & Haley,
1992; Dominguez, Barbagallo, Laurentani, Bandinelli, Bos et al., 2006; Manaa and Alhabib,
2012; Neilsen & Lukaski, 2006). Only one study has examined the effects of magnesiumcreatine chelate and alkaline creatine supplementation; thus further research is needed to
better understand the potential synergistic effect of magnesium and creatine on DOMS, an
effect currently not well understood.
Limitations of the Study
1. The participants were college-aged Western Washington University students, enrolled
in a physical education activity course; thus, conclusions are most relevant to similar
populations.
2. The measurement of DOMS is subjective and may vary depending on the perception
of the individual.
3. Previous training of the subjects could influence the results of the data. All subjects
had no prior experience with eccentric training.
4. Sex of subjects was not taken into account for the results. It is assumed that there is
no difference due to sex in muscle activation.
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Definition of Terms
Adenosine Triphosphate – A high-energy molecule that provides energy for muscle actions
(Baechle & Earle, 2008)
Concentric Muscle Action – When the muscle generates tension actively with visible
shortening in the length of the muscle (Hamill & Knutzen, 1995)
Delayed Onset Muscle Soreness (DOMS) – Pain or discomfort felt in skeletal muscles
following intense exercise with soreness increasing during the first 24 hours and peaking
during 24-72 hours post exercise (Armstrong, 1984)
Eccentric Muscle Action – When a muscle is subjected to an external force that is greater
than the internal force within the muscle, the muscle lengthens (Hamill & Knutzen, 1995)
Isometric Muscle Action – When a muscle generates force without changing length (Hamill
& Knutzen, 1995)
Residual Force Enhancement – Increased force generation as a result of sarcomere stretching
(Power, Rice, & Vandervoort, 2012)
Visual Analog Scale (VAS) – A 10-point pain scale, with 1 corresponding to feeling of no
soreness and 10 corresponding to feeling very, very sore, commonly used to evaluate the
intensity of pain (Scott & Huskisson, 1976)
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Chapter II
Review of Literature
Introduction
The purpose of this study was to assess the effect of magnesium-creatine chelate,
alkaline creatine and placebo supplementation on DOMS following high-intensity eccentric
muscle action. The benefits of eccentric training have been widely studied and, when
compared to concentric muscle action, eccentric muscle action has shown to elicit greater
force production and fatigue resistance with less muscle activation (Cooke, Rybalka,
Williams, Cribb, & Hayes, 2009; Faulkner, Brooks, & Opiteck, 1993). High-intensity or
prolonged eccentric muscle action is also the primary cause of exercise-induced muscular
injury making the benefits of eccentric training less available (Cooke et al. 2009; Newham et
al., 1983; Rawson et al. 2007; Rosene et al., 2009). This literature review will examine the
characteristics of eccentric muscle action, existing theories on the mechanism of exerciseinduced muscle injury and DOMS, and the role of creatine and magnesium as nutritional
supplements and potential aids in the attenuation of DOMS.
Eccentric Muscle Action
Eccentric muscle action is described as muscle lengthening under tension. This
muscle action occurs when the opposing force exceeds that of the muscle and causes the
muscle to lengthen (Hamill & Knutzen, 2006). Compared to concentric muscle action,
eccentric muscle action requires less metabolic energy, elicits less electromyographic (EMG)
activity and produces greater force outputs (Babault et al., 2001; LaStayo et al., 2003; Tesch,
Dudley, Duvoisin, Hather, & Harris, 2008). Ryschon, Fowler, Wysong, Anthony, and
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Balaban (1997) demonstrated the efficiency of eccentric muscle action compared to isometric
and concentric muscle action in the tibialis anterior and extensor digitorum longus by
measuring work while simultaneously measuring ATP, phosphocreatine, inorganic
phosphate, and pH during steady state exercise. During concentric action, phosphocreatine
was significantly reduced and ATP hydrolysis was significantly increased when compared to
eccentric and isometric action. Despite identical changes in muscle length during concentric
and eccentric action, metabolic costs of concentric action remained significantly greater than
that of eccentric action. A number of theories have been proposed to explain the underlying
mechanism for this observation (Schoenfeld, 2010).
Some theories suggest eccentric force outputs are due in part to changes in actinmyosin bonds (Flitney & Hirst, 1978). When muscle lengthens under tension, sarcomere
lengthening occurs as actin-myosin cross-bridges deform and ultimately detach from each
other. This mechanical disconnection exposes actin sites, making them available for myosin
heads to reattach to a new site. This continues until no more overlap between actin and
myosin exists. A classic study by Newham, McPhail, Mills, and Edwards (1983) assessed
ultrastructural changes of the quadriceps muscle following a 20-minute step test (step rate 15
steps/minute) intending to elicit one second of concentric muscle action in one leg and one
second of eccentric muscle action in the contralateral leg. All subjects reported very little
effort or exertion during eccentric muscle action and much more effort during concentric
muscle action, especially near the end of the session. Structural changes, including Z-line
movement and disorganization of the myofibrils were apparent immediately following
eccentric exercise and increased significantly 30 hours post-exercise. Post-exercise pain and
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tenderness developed only in the muscles involved in eccentric muscle action (Newham,
Mills, Quigley, & Edwards, 1983a).
A study by Power et al. (2012) examined the effect of eccentrically induced muscle
damage on residual force enhancement (RFE) of dorsiflexors. RFE protocol included
maximal activation of the dorsiflexors at 0° for one second, followed by a one-second stretch
at 30°/s, culminating with a three-second isometric contraction at 30° of plantarflexion.
Subjects then completed four sets of 25 eccentric isokinetic dorsiflexion contractions at 30°/s
through a 30° range of motion with 30 seconds rest in between sets. Following damaging
eccentric exercise protocols, significant 30.3 ± 6.4% and 36.2 ± 9.7% reductions in eccentric
torque and maximal voluntary contraction (MVC) were measured, respectively, compared to
baseline measures. However, following eccentric protocols, RFE increased significantly
compared to baseline, suggesting stretch prior to contraction attenuates decreased
performance outcomes due to muscle damage resulting from eccentric muscle action.
Further, a study by Vaczi et al. (2011) examined the mechanical, biochemical, and
electromyographic responses of the quadriceps muscle to high-intensity resistance training in
healthy, physically active men. Subjects assigned to the eccentric training group (group E),
completed six sets of 15 repetitions of isokinetic knee extension exercise at 60°/s through a
range of motion between 20°-80° of knee flexion. Training was completed on a total of seven
days (one day of rest was given following day three). Compared to baseline, maximum
voluntary isometric torque decreased significantly (-15%,) by day three, but increased
significantly (12%,) across all training days. Compared to concentrations of creatine kinase
(CK) on day one (202 ± 140 U/L), CK peaked significantly on day three (779 ± 332 U/L,)
and remained elevated through day seven, however, there were significant decreases in CK
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concentrations from day six (594 ± 321 U/L) and seven (337 ± 257 U/L). Compared to day
one measures, perceived soreness, assessed by questionnaire using a scale of 0 (not sore at
all) to 10 (very sore), peaked at 24 hours (average perceived soreness rating approximately =
5) and gradually decreased on all subsequent days. Soreness remained significantly elevated
on day four (average perceived soreness rating approximately = 2,) before returning to near
day one levels. These results suggest early (days one to three) attenuation of maximal
voluntary torque may be attributed to muscle damage and acute inflammation, as indicated
by significant increases in CK.
Acute inflammation from muscle injury is also known to increase production of
inflammatory markers, specifically CK and lactate dehydrogenase (LDH), and is implicated
in increased circulation of more global inflammatory markers, C-reactive protein and
interleukin-6 leading (IL-6) (Barnes, Trombold, Dhindsa, Lin, & Tanaka, 2010). Prolonged
circulation of inflammatory marker has serious health consequences including negatively
affecting the elasticity of arteries, resulting in a potentially unhealthy atherosclerotic response
(Ross, 1999). Exercise-induced, prolonged increases in concentrations of inflammatory
markers may also exacerbate chronic cases of low-grade inflammation, a condition often
present in deconditioned individuals.
Exercise-Induced Muscle Injury and DOMS
DOMS develops 24-48 hours after unaccustomed or high-intensity eccentric exercise
and is initially attributed to lengthening muscle action whereby sarcomeres are disrupted
(Armstrong, 1984; Byrnes et al., 1985; Newham, McPhail, Mills, & Edwards, 1983). Muscle
damage leads to inflammation as reflected by increased concentrations of inflammatory
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markers such as CK and LDH, which may inhibit injured muscle from repair resulting in
attenuated force outputs and reduced range of motion (Clarkson, Byrnes, McCormick,
Turcotte, & White, 1986; Cooke et al., 2009; Miles & Clarkson, 1994; Rosene et al., 2009;
Váczi et al., 2011). Additionally, muscle damage leads to cellular injury resulting in leakage
of inflammatory markers into extracellular fluid and plasma (Barnes et al., 2010).
Attenuation of DOMS post-eccentric exercise has important training implications. To
date, investigation of DOMS treatment predominantly includes massage, hydrotherapy, rest
and stretching routines (Mancinelli, Davis, Aboulhosn, Brady, Eisenhofer, & Foutty, 2006;
Sellwood, Brukner, Williams, Nicol, & Hinman, 2007; Volek, Duncan, Mazzetti, Staron,
Putukian, Go'mez et al., 1999). Mancinelli et al. (2006) evaluated the effects of muscle
massage on DOMS in the quadriceps muscles of NCAA Division I women's basketball and
volleyball players (n=24). DOMS was elicited through unaccustomed, high-intensity exercise
as part of each team's normal training plan and measures were made on day four of their
normal practice season. Pre- and post-measures in both groups (control and massage, each
n=12) included vertical jump, shuttle run and quadriceps femoris length. Additionally,
subjects were asked to rate their level of muscular soreness utilizing a pain pressure threshold
scale of 1-10. Subjects in the control group rested while subjects in the massage group
received the massage protocol. The control group reported no significant change in soreness
during pre- and post-measures and performed similarly across all tests. Within the massage
group, the average pre-massage rating of perceived soreness was 5 out of 10 and the average
post-massage rating of perceived soreness was 3 out of 10 resulting in significantly reduced
perceived soreness post-treatment (p=0.0011). Subjects in the massage group also
significantly improved performance in the vertical jump test by increasing the average jump
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height by 0.04 cm (p=0.0033). No performance differences were seen in any other measures.
This study suggests massage may be a reasonable intervention to alleviate DOMS thereby
helping athletes and others improve performance during repeated bouts of high-intensity
exercise. Other studies evaluating the effects of massage on DOMS suggest massage is
effective at alleviating perceived symptoms of DOMS but has no conclusive effect on
improved performance during exercise (Best, Hunter, Wilcox, & Haq, 2008).
Hydrotherapy, in the form of cold- or hot-water immersion, is another commonly
used treatment for DOMS (Howatson, Goodall, & Van Someren, 2009; Sellwood, Brukner,
Williams, Nicol, & Hinman, 2007; Vaile, Halson, Gill, & Dawson, 2008). Some studies
show cold-water immersion to be ineffective, eliciting no changes in pain perception,
swelling, maximal isometric strength, or concentrations of serum creatine kinase (Howatson
et al., 2009; Sellwood et al., 2007) while others show improvements across some
performance variables, such as the isometric squat and improved perceptions of pain
following cold water immersion therapy (King & Duffield, 2009; Pointon et al., 2011; Vaile
et al., 2008). Vaile et al. (2008) examined the effects of three different water therapy
interventions on DOMS following high-intensity exercise protocol. In a randomized
crossover design, subjects (n=38 strength trained men) completed two experimental trials
separated by eight months. One trial involved passive recovery (PAS) for all subjects, 14
minutes of seated, inactivity, and the other utilized one of three water therapy interventions,
each for 14 minutes: cold water immersion (CWI: full-body immersion, excluding head and
neck in15°C water); hot water immersion (HWI: full-body immersion, excluding head and
neck, in 38°C water); or contrast water therapy (CWT: full-body immersion, excluding head
and neck, alternating every minute between hot and cold). Exercise protocol consisted of five
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sets of 10 eccentric bi-lateral leg press contractions with a load of 120% of 1-RM followed
by two sets of 10 repetitions at a load of 100% of 1-RM. Experimental measures included
weighted squat jump, isometric squat, perceived pain (visual analog scale of 0 to 10) and
thigh girth and concentrations of inflammatory markers creatine kinase, lactate
dehydrogenase and interleukin-6, all of which were evaluated immediately after, and at 24,
48 and 72 hours post-exercise. Experimental measures for each hydrotherapy intervention
group were compared to measures from the PAS group.
Percent change from baseline in isometric squat performance for subjects in the HWI
was reduced significantly at 24, 48 and 72 hours post exercise (-12.8%, -10.1% and -3.2%;
p<0.05) compared to PAS (-17.0%, -16.0%, -9.8%). A significant change at 24, 48, and 72
hours post exercise was also demonstrated following CWT (-10.3%, -7.4%, -2.8%; p<0.01)
compared to PAS (-17.3%, -14.0%, -11.5%). Additionally, change in peak performance
power (% of change from baseline) was significantly less for CWI at 48 hours (-7.0%;
p=0.01) and 72 hours (-4.0%; p=0.03) post-exercise following as compared to PAS at 48 and
72 hours (-16% and -8%). However, HWI did not positively affect recovery for squat jump
performance compared to PAS. Both CWT and CWI interventions elicited significant
(p<0.01 and p<0.03) reductions in swelling at 24, 48 and 72 (CWT: 56.4 ± 4.5, 56.3 ± 4.6,
56.3 ± 4.5; CWI: 57.1 ± 3.8, 56.9 ± 3.8, 56.9 ± 3.8) hours post-exercise compared to PAS
(CWT: 56.9 ± 4.7, 56.9 ± 4.7, 56.7 ± 4.7; CWI: 57.1 ± 3.8, 56.9 ± 3.8, 56.9 ± 3.8). Compared
to PAS (average VAS at 24, 48 and 72 hours post exercise approximately= 6, 8, 5) perceived
pain was significantly (p<0.01) reduced at 24, 48 and 72 hours post-exercise following CWT
(average VAS at 24, 48 and 72 hours post exercise approximately = 5, 6, 4). Both CWI and
HWI were ineffective in pain reduction post exercise. Additionally, Vaile et al. (2008)
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observed significant reductions in creatine kinase at 24, 48 and 72 hours post-exercise
following CWI and 48 hours following HWI. Pointon et al. (2011) also found cold-water
therapy results in lower perceptions of pain, however no changes in concentrations of
inflammatory markers (creatine kinase and asparate aminotransferase) were observed postexercise.
Stretching has also been identified as a possible method for attenuating the effects of
DOMS (Chen, Nosaka, Chen, Lin, Tseng, & Chen, 2011; Henschke & Lin, 2011). Chen et al.
(2011) studied the effects of eight weeks of static stretching (SS) and proprioceptive
neuromuscular facilitation (PNF) on DOMS after six sets of high-intensity eccentric muscle
action of knee flexors. After eight weeks of flexibility training, both groups improved range
of motion significantly and showed significant increases in isokinetic concentric strength of
knee flexors (SS = 11% ± 3%, PNF = 16% ± 4%). The decrease in peak torque across all six
sets of eccentric muscle action was significantly greater for the control group (18% ± 4%)
when compared to both SS (12% ± 2%) and PNF (10% ± 2%) groups. Both SS and PNF
groups performed significantly more work during the eccentric exercise test and
demonstrated improved performance following 5-day recovery period when compared to
controls. This research supports the use of flexibility training, either SS or PNF, as an
effective intervention for DOMS.
Successful management of DOMS has yet to be determined though interventions such
as water-therapy, massage, and stretching are being explored. The role of creatine in energy
production during muscle action makes creatine supplementation a potential player in
decreasing exercised-induced DOMS. Magnesium is another known anti-inflammatory agent
and could potentially lead to reduced DOMS when coupled with creatine supplementation.
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Role of Creatine
Creatine is one of the most popular and well-researched ergogenic aids available
(Cooper, Naclerio, Allgrove, & Jimenez, 2012; Lawler, Barnes, Wu, Song, & Demaree,
2002). Creatine is produced in the kidney, pancreas, and liver from three amino acids
(glycine, arginine, and methionine) and 95% of total intracellular creatine (free and
phosphorylated) is located in skeletal muscle (Persky & Brazeau, 2001). Phosphorylated
creatine, or phosphocreatine (CrP), plays an essential role in ATP synthesis via the
Phosphagen System (Bessman & Carpenter, 1985). CrP reacts with ADP and hydrogen ions
via the enzyme creatine kinase, resulting in ATP and free creatine. This reaction happens
quickly, during initial seconds of high-intensity anaerobic exercise, and newly synthesized
energy is then translocated from the site of production to the site of use (Persky & Brazeau,
2001). CrP also serves as an energy reservoir and a buffer of hydrogen ions, delaying the
onset of acidosis as a result of increased lactate production during exercise (Walsh,
Tonkonogi, Söderlund, Hultman, Saks, & Sahlin, 2001). During recovery, CrP stores are
replenished up to 80-90% of their resting values within two minutes (Walsh et al., 2001).
Some research shows creatine supplementation reduces exercise-induced muscle
damage as evidenced by significant reductions in concentrations of inflammatory markers
such as CK and LDH, and improved performance during recovery time (Bassit et al., 2008;
Cooke et al., 2009; Santos et al., 2004). In a double-blind study, Bassit et al. (2010) assessed
the effects of short-term creatine supplementation on inflammatory markers for muscular
damage. Eight experienced triathletes were randomly assigned to either a control or creatine
group. Five days prior to competition, the control group ingested a maltodextrin supplement
(50 grams per day) and the creatine group ingested the same amount of maltodextrin
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supplement plus creatine (20 grams per day). Blood samples were collected before, 36, and
60 hours after competition and plasma concentrations of CK, lactate dehydrogenase (LDH),
aldolase (ALD), glutamic oxaloacetic acid transaminase (GOT), glutamic pyruvic acid
transaminase, and C-reactive protein (CRP) were assessed. This study also measured plasma
concentrations of CK and LDH and muscle vascular permeability in the gastrocnemius
muscle of rats. Plasma levels of CK, LDH, ALD, GOT, and GPT were significantly reduced
in the creatine group (CK increased 5-fold, p<0.01; LDH showed no changes; ALD increased
2.9-fold, p<0.01; GOT showed no changes; GPT showed no changes ) as compared to the
control (CK increased 11-fold, p<0.001; LDH increased 1.7-fold, p< 0.05; ALD increased by
3.9-fold, p<0.001; GOT increased 4.2-fold, p<0.01; GPT increased 1.9-fold, p<0.05). In the
rat study, CK and LDH levels were reduced and muscle vascular permeability was
significantly reduced in the creatine group.
An earlier study by Bassit et al. (2008) examined the effects of creatine
supplementation on the change in inflammatory markers following a triathlon competition.
Post-competition, Bassit et al. (2008) observed significantly reduced increases in
concentrations of tumor necrosis factor-alpha (TNF-α), interferon-alpha (IFN-α), interleukin1 beta (IL-1β), and plasma prostaglandin E2 (PGE2) in the creatine group when compared to
controls. Post-race results for the creatine group show inflammatory marker TNF-α at 24 and
48 hours was reduced by 42 and 64% to 166.64 ± 9.54 pg/ml and 117.22 ± 5.55 pg/ml; IFN-α
at 24 and 48 hours was reduced by 50.5 and 80.1% to 147.08 ± 2.46 pg/ml and 58.24 ± 6.10
pg/ml; IL-1β at 24 and 48 hours was reduced by 72 and 71% to 43.86 ± 5.67 pg/ml and 45.82
± 3.23 pg/ml; and PGE2 at 24 and 48 hours was reduced by 85.5 and 91% to 65.70 ± 5.85
pg/ml and 52.56 ± 7.10 pg/ml. All concentrations of inflammatory markers reported above
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are significantly lower than those in the control group at 24- and 48-hours post-race. In this
experiment, interleukin-6 (IL-6) levels remained consistent across groups however other
research shows changes in IL-6 concentrations in response to exercise (Barnes et al., 2010;
Deldicque, Atherton, Patel, Theisen, Nielsens, Rennie, & Francaux, 2008). More research is
needed to determine if short-term creatine supplementation significantly lowers
concentrations of inflammatory markers post high-intensity exercise (Bassit et al., 2010; R.
Bassit et al., 2008; Cooke et al., 2009; Santos et al., 2004).
A study by Rosene et al. (2009) examined the role of creatine supplementation on
reducing acute and longer-term exercise-induced muscle damage thus aiding in recovery
following eccentric training. Twenty, physically active males were randomly assigned to a
creatine or placebo group. Subjects in the creatine group consumed a loading (20grams per
day day for seven days) and sustaining (6 grams per day for 29 days) dose of creatine while
the placebo group consumed equal amounts of a placebo (exact placebo not specified in
research, supplied by AST Sports Science). On day eight, subjects performed knee extension
eccentric exercise to induce knee extensor muscle damage. On day 30, subjects repeated the
protocol on their non-dominant leg using 150% of one repetition maximum (1-RM) of nondominant leg. The protocol consisted of a warm-up bout (1 set of 10 at 50%) followed by 7
sets of 10 reps at 150% of concentric 1-RM with 15 seconds between each repetition with
three minutes rest between sets. Blood concentrations of inflammatory markers CK and LDH
were collected prior to exercise and at 12, 24, and 48-hours post-exercise. Maximum
Isometric Force (MIF) was determined for subjects sitting with leg positioned at
approximately 45 degrees of knee flexion. Muscle dynamic strength (MDS) of the dominant
(acute) and non-dominant (longer-term) thigh was assessed using a seated leg extension
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machine after which the eccentric load was set at 150% of the concentric 1-RM. Knee range
of motion (KROM) and perceived soreness were also assessed. Perceived soreness was
evaluated by each subject placing a mark along a 25.4 cm scale, with 0 indicating no muscle
soreness and 25.4 cm indicating very, very sore. MIF, MDS, KROM, and soreness were
evaluated 12-hours post-eccentric exercise and every 24 hours for the next five days.
Performance and blood tests after eight days of creatine supplementation resulted in no
differences between groups indicating that creatine supplementation does not reduce
exercise-induced muscle damage after short-term supplementation. This is contrary to a
result reported earlier. After 30 days of creatine supplementation, maximum isometric force
outputs improved significantly when compared to the performance by subjects in the placebo
group (approximately 245Nm vs. 195 Nm for creatine and placebo respectively). Rosene et
al. (2009) suggests this may be due to decreased exercise-induced muscle damage after
longer periods of supplementation time or could be attributed to hypertrophy of muscle fibers
and not to decreased damage at all.
Effects of Creatine Supplementation on Strength
Numerous studies have examined the effect of creatine supplementation on strength
and increases fat free mass, both of which are improved with resistance training (Buford,
Kreider, Stout, Greenwood, Campbell, Spano et al., 2007; Byrnes et al., 1985; P. Greenhaff,
Bodin, Soderlund, & Hultman, 1994; Lawler et al., 2002; Rawson & Volek, 2003; Volek et
al.,1999). Creatine supplementation may lead to enhanced strength gains in bench press,
squat, elbow flexion, deadlift, and leg press (Kreider, Ferreira, Wilson, Grinstaff, Plisk, et al.,
1997; Cribb & Hayes, 2006; Becque, Lochman, & Melrose, 2000; Herda et al., 2009; Saremi,
Gharakhanloo, Sharghi, Gharaati, Larijani, et al., 2010). A widely reviewed study by Kreider
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et al. (1997) examined the effects of 28-days of creatine supplementation on strength and
performance in 25 NCAA division I football players. Players were assigned to either the
placebo group (placebo consisted of 99 g/day of glucose, 3 g/day of taurine, 1.1 g/day of
disodium phosphate, and 1.2 g/day of potassium phosphate) or the creatine group (placebo
plus 15.75 g/day of creatine monohydrate). Pre- and post-supplement strength and power
testing included bench press, squat and power cleans. DEXA scan for body mass (placebo
0.77 ± 1.8; creatine 2.22 ± 1.5 kg) and fat free mass (placebo 1.33 ± 1.1; creatine 2.43 ± 1.4
kg) were significantly increased in the creatine group. Bench press lifting volume (placebo -5
± 134; creatine 225 ± 246 kg) and the sum of bench press, squat, and power clean lifting
volume (placebo 105 ± 429; creatine 1,558 ± 645 kg) were significantly increased in the
creatine group. Thus, elite athletic performance may be significantly enhanced by creatine.
More recently, Herda et al. (2009) examined the effects of 28-days of creatine
supplementation (5 g creatine per day) without resistance training on 1RM for leg press and
bench press. When compared to the placebo (3.6 g of microcystalline cellulose per day),
subjects taking creatine showed significant increases in both 1RM for bench press
(approximately 8% increase) and leg press (approximately 10% increase). Saremi et al.
(2010) examined the effects of resistance training (three days per week for eight weeks) and
creatine supplementation on 1RM for leg press and bench press in healthy, college-age men.
Subjects (n=8) in the creatine group completed the resistance training program while
supplementing creatine with a loading dose equivalent to 0.3 g/kg body weight per day for
one week followed by a maintenance dose equivalent to 0.05 g/kg body weight per day for
seven weeks. Subjects in the placebo group consumed placebo (cellulous power) and
completed the resistance training protocol. Compared to the placebo group, subjects taking
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creatine showed significant increases in 1RM for bench press at week four (placebo 59.5 ±
9.3; creatine 64.87 ± 5.9) and week eight (placebo 63.02 ± 10.1; creatine 71.75 ± 7.7). The
creatine group also showed significant increases in 1RM for leg press at week four (placebo
165.25 ± 13.9; creatine 160.62 ± 14.2) and at week eight (placebo: 172.12 ± 14.5;
creatine166.87 ± 12.5).
Research also shows that lower doses of creatine supplementation ingested before and
after a bout of resistance training may positively affect strength gains (Candow, Chilibeck,
Burke, Mueller & Lewis, 2010; Cribb & Hayes, 2006). In a double blind, repeated measures
study, Candow et al. (2010) examined the effects of creatine supplementation frequency on
muscle size and strength. Subjects (n=38 physically active, non-resistance trained college
students) were randomly assigned to one of four groups: CR2 (0.15 g/kg creatine during 2
days/week of resistance training), CR3 (0.10 g/kg creatine during 3 days/week of resistance
training, PLA2 (rice flour placebo during 2 days/week of resistance training) and PLA3 (rice
flour placebo during 3 days/week of resistance training). All groups completed six weeks of
resistance training protocol which included leg press, chest press, lat pull-down, shoulder
press, knee flexion and extension, triceps extension, biceps curl, and standing calf raise.
Subjects in CR2 and PLA2 performed 3 sets of 10 repetitions for each exercise at 80% of
1RM on 2 days/week. Subjects in CR3 and PLA3 performed 2 sets of 10 repetitions for each
exercise at 80% of 1RM on 3 days/week. Baseline and post-training measurements of elbow
and knee flexor and extensor thickness and leg press and chess press 1-RM strength were
collected. Urinary microalbumin and diet were also assessed. Results show the frequency of
resistance training (2 vs. 3 days/week) had no significant effect on body mass, muscle
thickness, and strength. Post hoc analysis for body mass showed significant increases in the
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CR2 (1.8 ± 0.2 kg) and CR3 (1.5 ± 0.4 kg) groups when compared to PLA3 (0.2 ± 0.3 kg).
All groups experienced significant increases in muscle thickness with the CR2 (0.6 ± 0.9 cm)
and CR3 (0.4 ± 0.6 kg) groups increasing significantly when compared to PLA2 (0.05 ± 0.5
cm) and PLA3 (0.13 ± 0.7 cm). Leg press and chess press strength increased by 63.1 ± 57 kg,
35 ± 25 kg, 40 ± 35 kg, and 40 ± 18 kg for CR2, CR3, PLA2, and PLA3 respectively.
Though there was no significant difference in strength gain between groups, men who
supplemented creatine did show significantly greater strength gains in leg press when
compared to women supplementing creatine (77.3 ± 51.2 kg and 21.3 ± 10 kg for men and
women on creatine, respectively). These results show that creatine supplementation pre- and
post-resistance training elicits increased muscle thickness and that equal doses of creatine on
2 or 3 days/week elicit similar increases in muscle thickness and strength. In addition, results
show that men taking creatine may experience greater strength gains than women taking
creatine.
Furthermore, a study by Chilibeck et al. (2004) examined the effects of creatine (0.2g
Cr/kg body weight) supplementation and placebo (equal amount of corn starch) immediately
post-exercise during six weeks of resistance training on muscle thickness and strength in men
and women. Without regard for sex, results showed creatine supplementation led to
significant increases in muscle thickness of elbow flexors (creatine 0.32 ± 0.07 cm; placebo
0.24 ± 0.07 cm with and without creatine supplementation, respectively) and trended toward
significance for knee extensors (0.22 ± 0.09 cm and 0.14 ± 0.09 cm with and without creatine
supplementation, respectively). Bench press strength showed significant increases over time
(p<0.01) with creatine supplementation eliciting greater strength gains compared to nonsupplemementation (29 ± 2.0 kg and 17 ± 3.0 kg) and males eliciting greater strength gains
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compared to females (27 ± 3.0 kg and 19 ± 3.0 kg). With regard to elbow flexor thickness,
both males and females increased (p<0.05) but males increased more than females (0.3 ± 0.1
and 0.2 ± 0.1 cm, respectively). These results show that creatine supplementation directly
following resistance training can lead to increased muscle size in upper limbs and may be
more effective in males.
Research on short-term (five to seven days) creatine-loading shows mixed results.
Some studies show short-term creatine loading also improves strength performance (Law,
Ong, GillianYap, Lim & Chia, 2009; Rossouw, Kruger, & Rossouw, 2000) while other
studies show no significant increases in strength as a result of supplementation (Zungia,
Housh, Camic, Hendrix, Russell, et al., 2012).
Role of Magnesium
Magnesium is the fourth most abundant mineral in the body and plays a vital role in
many reactions essential to healthy functioning, including muscular action, blood pressure,
and glycogen breakdown (Weaver & Nieves, 2009). Increasing daily ingestion of magnesium
may positively affect many inflammatory conditions such as metabolic syndrome,
hypertension, and type-2 diabetes (Hata, Doi, Ninomiya, Mukai, Hirakawa et al., 2013; AlDelaimy, Rimm, Willett, Stampfer, & Hu, 2004; Chacko, Sul, Song, Li, LeBlanc, You et al.,
2011; Rayssiguier, Libako, Nowacki, & Rock, 2010; Song, Manson, Buring, & Liu, 2004).
Magnesium supplementation has also been reported to improve performance, due to its role
in ATP production, and has recently shown to support down-regulation of genes related to
inflammatory pathways (Chacko et al., 2011; Lukaski & Nielsen, 2002). Research shows
intra- and extracellular concentrations of magnesium fluctuate with exercise (Laires &
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Monteiro, 2007). Some research shows submaximal exercise over a long period of time
results in decreased concentrations of plasma magnesium due to loss through perspiration
and urination (Stendig-Lindberg, Shapiro, Epstein, Galun, Schonberger, Graff et al., 1987).
Magnesium deficiency leads to activation of immune cells such as macrophages and
neutrophils and up-regulation of genes associated with inflammatory pathways. Additionally,
magnesium deficiency is reported to up-regulate Vascular Cell Adheasion Molecule-1
(VCAM) and Plasminogen Activator Inhibitor-1 (PAI) thereby increasing thrombosis and
atherosclerosis (Maier, Malpuech-Brugère, Zimowska, Rayssiguier, & Mazur, 2004). The
inflammatory response resulting from magnesium deficiency relates to cytosolic calcium
elevation and results in inhibition of macrophages and promotes stabilization and reduction
of plaque (King, 2009). Another way magnesium may contribute to anti-inflammatory
pathways is through its role in maintaining low triglyercide levels, which increase with
hypomagnesemia (Nassir, Mazur, Giannoni, Gueux, Davidson, & Rayssiguier, 1995).
Epidemiologic studies offer even greater insight into the role and importance of magnesium.
Guerrero-Romero et al. (2002) examined C-reactive protein levels in obese individuals and
found that individuals with the lowest magnesium intakes were twice as likely to have
significantly increased C-reactive protein. Song et al. (2006) found magnesium intake was
inversely proportional to C-reactive protein levels. It is the anti-inflammatory effects as well
as the role of magnesium in hundreds of biological reactions, including ATP production and
cell permeability that supports the need for more research on the effects of magnesium
supplementation on DOMS.
Selsby et al. (2004) conducted one of the only existing studies to examine the effects
of creatine and magnesium-creatine chelate supplementation on exercise performance.
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Thirty-one weight-trained subjects were randomly assigned to a placebo, creatine, or
magnesium-creatine chelate group and each subject ingested 2.5 grams of their respective
supplement or placebo for seven days. At baseline and after 10 days, subjects completed a 1RM bench press test and a fatigue test. The fatigue test was performed at 70% 1-RM during
which subjects performed the lengthening and shortening phase of the bench press each in
one second. The fatigue test ended when subjects could no longer complete the full
repetition or could not maintain the proper cadence. Work was then calculated. Postsupplementation results showed the creatine and magnesium-creatine chelate groups both
performed significantly more work (6,658 ± 306 J and 7,647 ± 524 J, respectively) than the
placebo group (6,196 ± 437 J) when compared to baseline measures (6,239 ± 535 J, 5,613 ±
427 J and 6,384 ± 438 J). There was no significant difference in total work for the creatine
and magnesium-creatine chelate group (6,658 ± 306 J vs. 7,647 ± 524 J). In this particular
study, the first of its kind to demonstrate such low doses of creatine may improve
performance in short, high-intensity bouts of exercise, magnesium-creatine chelate did not
improve performance more than creatine ingestion. Though this research shows a lack of
effect, the researchers feel their theory on a new mechanism for creatine transport is viable
and requires further investigation. Due to the side effects of magnesium on the
gastrointestinal tract, there was a limit to how much magnesium and creatine supplement
could be ingested in this study.
Effect of Magnesium Supplementation on Strength
Magnesium deficiency affects muscle function and results in strength reductions,
cramps, and muscle fiber damage during exercise and sport (Benardot, 2012). Athletes
participating in sports that categorize individuals by weight are often susceptible to
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magnesium deficiency due to dehydration as a result of rapid weight loss (Lakasaki, 2001).
Investigations of the effects of dietary magnesium on muscular strength suggest magnesium
deficiency is correlated with decreased performance in handgrip strength, knee extension
torque, lower-leg muscle power, and ankle extension strength (Dominguez, Barbagallo,
Lauretani, Bandinelli, Bos et al., 2006). Furthermore, a study by Matias, Santos, Moneiro,
Silva, Raposo, et al. (2010), evaluated the effects of magnesium changes on strength in elite
male athletes (n=20) who participate in the sport of judo. Serum magnesium, intracellular
water, fat-free mass, nutrient intake, and maximal strength were measured at baseline
(hydrated state) and pre-competition. Maximal handgrip strength was measured using a
dynamometer and upper body power was measured using a computer-interfaced bench press
machine. Subjects who lost more than 2% intracellular water from baseline to precompetition measures also lost a significant amount of red blood cell magnesium (44.8 ±
36.8% loss) and showed decreased performance (-4.6 ± 6.6%) in handgrip strength test. This
result positively correlates magnesium blood loss with decreased handgrip strength.
Another study by Santos et al. (2011) evaluated the effects of magnesium levels on
elite male basketball, handball, and volleyball players. Strength tests included maximal
isometric trunk flexion, extension, and rotation, handgrip, squat and countermovement
Abalakov jump, and maximal isokinetic knee extension and flexion peak torques. Seven-day
nutrition logbooks were assessed to determine individual magnesium levels and correlation
to performance on strength tests. Results showed the average level of magnesium intake in
these athletes (244.7 ± 78.8 mg) to be significantly (p<0.001) lower than the recommended
daily allowance of magnesium (400 mg). Regression analysis indicated that magnesium
intake was directly associated with trunk flexion (R2=0.193, p<0.025), trunk rotation
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(R2=0.357, p<0.073) and handgrip strength (R2=0.111, p<0.096). After adjusting for energy
intake, these associations remained significant: trunk flexion (p <0.028), trunk rotation
(p<0.055) and handgrip strength (p <0.027).
Brilla and Haley (1992) examined the effects of magnesium supplementation on a 7week strength training program in untrained subjects. Compared to controls, subjects taking
the magnesium supplement (total daily intake, including dietary magnesium, was 8g/kg body
weight/day) showed significant (p<0.05) increases in absolute quadriceps torque, (211 vs.
174 Nm) relative torque adjusted for body weight (3.07 vs. 2.58 Nm/kg), and relative torque
adjusted for lean mass (3.84 vs. 3.36 Nm/kg). The results of this study reflect the significant
role of magnesium in torque gains after strength training while the results of the studies
presented earlier reflect the impactful effects of magnesium deficiency on strength.
Effects of Creatine and Magnesium on Fatigue
Resistance to exercise-induced fatigue may be enhanced by creatine (Rawson, Stec,
Fredrickson, & Miles, 2011; Hoffman, Stout, Falvo, Kang, & Ratamess, 2005) and
magnesium (Cheng et al. 2010). Compared to a placebo group (specific placebo not listed),
Rawson et al. (2011) observed significant resistance to fatigue in subjects (n=10) who
ingested a creatine supplement (0.03 g/kg body weight/day) for six weeks. The fatigue test
consisted of 5 sets of 30 repetitions of knee extension at 180°/sec. Each set was assigned a
score based on the summation of the 30 peak torques generated during the set. While there
were no significant changes in maximum strength (3RM concentric knee extension test at
180°/sec), body mass, fat free mass, or total body water, plasma creatine significantly
increased (+182%, range 0-129 mmol/L) in subjects in the creatine group. The creatine group
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was also shown to be more fatigue resistant than the placebo group in set 2, 3, 4, and 5 by
7%, 9%, 9%, and 11% respectively.
Hoffman et al. (2005) examined the effects of low dose creatine supplementation (6
g/day) over six days with pre- and post-fatigue tests consisting of three, 15-second Wingate
tests. No significant change in peak power, mean power, or total work were observed,
however, change in the rate of fatigue of total work was significantly lower in the creatine
group as indicated by an elevated linear slope for the creatine group. These results are similar
to those reported in other fatigue research (Selsby, 2004) and suggest that larger doses of
creatine may not be necessary to realize the benefit of enhanced fatigue resistance.
Magnesium supplementation has been reported to improve performance and resist
fatigue due to its role in ATP production (Lukaski & Nielsen, 2002). A study by Chen et al.
(2010) examined the effects of magnesium sulfate supplementation on swimming
performance in rats. Researchers observed increased glucose and magnesium levels (175%
and 302% of basal levels) with pre-treatment of magnesium sulfate in non-swimming rats. In
rats forced to swim, pre-treatment of magnesium sulfate reduced lactate levels 150% of basal
during swimming. Magnesium levels also increased significantly during forced swimming
and recovery (152-144% of basal). Another study of patients with chronic obstructive
pulmonary disorder found that 2g of magnesium sulfate positively affects maximal exercise
in patients as compared to 2g of placebo (saline) (do Amaral, Rodrigues-Junior, Terra
Filho,Vannucchi, & Martinez, 2008). COPD patients receiving magnesium significantly
improved performance on the cycle ergometer cardiopulmonary exercise test by pedaling for
53 seconds longer (p = 0.011) and reaching a workload of 8.0 (p =0.018). Thus, magnesium
supplementation has been shown to attenuate lactate production and increases glucose and
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exercise time thereby making a person’s exercise more sustainable and less susceptible to
fatigue.
Summary
Eccentric muscle action elicits many benefits but, as indicated in earlier sections, is
also the primary cause of muscle-induced injury, DOMS and inflammation. Acute
inflammation from muscle injury is also known to increase production of inflammatory
markers, specifically CK and lactate dehydrogenase (LDH), and is implicated in increased
circulation of more global inflammatory markers. Creatine and magnesium both may play a
crucial role in the attenuation of exercise-induced muscle damage, inflammation, and
enhancement of normal physiological gains form exercise. As a result, this study’s
examination of magnesium-creatine chelate, alkaline creatine compound and placebo
supplementation on DOMS following high-intensity eccentric muscle action adds to the
understanding of supplementation effects on DOMS.
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Chapter III
Methods and Procedures
Introduction
The purpose of this study was to assess the effects of magnesium-creatine chelate,
alkaline creatine compound and placebo supplementation on DOMS following eccentricallyinduced muscle damage. DOMS was induced using a device that required subjects to resist
loads at 65% of their relative maximum value.
Description of Study Population
Thirty-six young (18-24 years old), healthy, recreationally active individuals were the
subjects for this project. Subjects were chosen randomly based on their volunteer responses
and were physically active students from Western Washington University. Prerequisite to
participation, each subject completed an informed consent form previously approved by the
institution’s Human Subjects Committee, in accordance with the National Institute of Health
guidelines (Appendix A). Informed consent was obtained from all subjects (Appendix B).
Subjects who had supplemented magnesium or creatine in their habitual diet within 60 days
prior to orientation or any who were suffering from kidney, liver, or endocrine disease or any
disorder that might affect normal cellular levels of creatine or fluid balance (or both) were
excluded. The medical history questionnaire filtered any subjects taking any substance
classified as a diuretic, other than caffeine, in their habitual diet. Subjects were instructed to
keep exercise regimens consistent throughout the study.
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Design of Study
The design of the study followed a double blind, three-group format analyzed pre and
post a four-week treatment period. Each subject was randomly assigned to one of the
following groups: alkaline creatine, magnesium-creatine chelate or placebo group. During the
treatment period, subjects in the alkaline creatine group ingested 5 g of creatine plus an
alkalizing agent, soda ash, each day. Subjects in the magnesium-creatine chelate group
ingested 5 g of creatine plus 400 mg of magnesium, a dose of magnesium that is equivalent
to 100% or the recommended daily allowance (RDA) (Institute of Medicine (US) Standing
Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997). Subjects in the
placebo group ingested 5 g dextran per day. All subjects were instructed to take their
respective supplements with 16 oz (0.47 L) of liquid. The treatment period was four weeks to
allow for tissue saturation.
Comparisons were made from baseline, between and within groups for DOMS using
an eccentric machine and weight using a balance beam scale. Exercise testing was conducted
at the same time of day at baseline and after the treatment period. Post-treatment data
collection also included height, measured by stadiometer.
Data Collection Procedures
All testing was performed in the Biomechanics Laboratory at Western Washington
University. The testing procedure lasted an average of 30 minutes with the exercise protocol
lasting five minutes.
Subjects completed an eccentric training session using a prototype eccentric trainer.
The device pedals perform a cyclic unilateral motion requiring eccentric muscle action of the
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hip and knee extensors. The eccentric trainer includes a performance monitor displaying
force production during exercise. This exercise and machine were used for the purpose of
eliciting DOMS. The subjects experienced a brief familiarization protocol with the eccentric
device. This protocol consisted of a mid-range velocity set at 35 cycles per minute. During
the familiarization period, the subjects were asked not to resist the machine to an extent that
could cause fatigue. When the subjects became familiar with the motion, peak eccentric force
was obtained on the eccentric trainer at the velocity of 35 cycles per minute. The average of
three maximal eccentric contractions was used to establish each subject's workload.
After the maximal values were calculated, the subjects were instructed to get off the
eccentric machine and take a five-minute rest prior to their testing session. During the rest
period, subjects were allowed to walk, stretch or sit-down in order to obtain a sufficient
recovery. During the initial moments of the test, subjects were given a few repetitions to
become comfortable with the velocity of the movement. After this brief re-familiarization,
subjects were instructed to maintain a force of 65% of the peak eccentric force for the full
training session. The testing session consisted of five minutes of continuous work, an
exercise duration thought to elicit DOMS (Clarston et al., 1988)
DOMS measurements were assessed 12, 24, 48, 60, and 72 hours post-exercise.
Subjects were instructed to send an email with a muscle soreness score that corresponded to
the visual analog scale (Appendix C) with scores from 1 (normal) to 10 (very, very sore).
Subjects were also instructed to refrain from rigorous exercise until the last muscle soreness
questionnaire was completed. During the four-week training period, subjects continued their
normal activities.
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Descriptive statistics were calculated. Data were analyzed using a group by time
mixed ANOVA at an alpha level of 0.05. Data analysis was done with Microsoft Excel 2007
and SPSS software version 11 (Chicago, IL).
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Chapter IV
Results and Discussion
Introduction
The purpose of this study was to assess the effects of magnesium-creatine chelate,
alkaline creatine compound, and placebo supplementation on DOMS following a bout of
eccentric muscle action. At baseline and post-treatment period, subjects completed one fiveminute bout of eccentric knee and hip extensor exercise. Following both bouts of exercise,
subjects reported muscle soreness on a visual analog scale every 12 hours for 72 hours post
exercise. Comparisons were made between and within groups for DOMS and weight at
baseline and post-treatment period. Pre-treatment data collection also included height.
Subject Characteristics
Thirty-six subjects participated in this study. Twelve subjects were assigned to the
alkaline creatine group (M: 6, F: 6), 13 subjects to the magnesium-creatine chelate group (M:
7, F: 6) and 11 subjects to the placebo group (M: 8, F: 3). The number of subjects’ data
included in the data set (Appendix D) is much smaller than originally expected, due to
incomplete reporting from subjects. Despite email reminders, many subjects neglected to
submit their pain scale reports as required. This resulted in attrition of two subjects from each
creatine group and seven from the placebo group. There were no significant differences in
subject physical characteristics (p>0.05). Group data are presented in Table 1.

	
  

31	
  

Table 1: Subject Characteristics

Mean
SD

20.45
2.21

Height
(cm)
173.08
12.92

Mean

21.17

175.03

77.09

77.57

2.21

9.97

17.26

17.57

21.85

175.99

76.68

77.32

1.82

10.84

14.38

14.71

Group
Placebo

Age

Weight
Pre (kg)
70.15
12.86

Weight Post
(kg)
70.93
13.32

Alkaline
Creatine

SD
Mg Creatine
Chelate

Mean
SD

Results
Delayed Onset Muscle Soreness
There were no significant interaction effects (F[5,1.95] = 0.36, p = 0.86). The creatine groups
did have significant main effects pre to post testing in DOMS using a visual analog scale
after a 5-minute eccentric bout of exercise (F[5,26.95] = 5.23, p = 0.0002). The effects were
observed at 12, 24, and 36 hour intervals for the alkaline creatine subjects and at 12 hour
intervals up to the 60 hour interval for the magnesium-creatine chelate group. The descriptive
data are presented in Table 2. A display of group responses from the pre-test are displayed in
Figure 1 and the post-test results are shown in Figure 2. The finding that the placebo group
scores were higher at all times in the post-test is demonstrated in Figure 3. However, they
were not significantly different from the pre-test data (p >0.05).

	
  

32	
  

Table 2. DOMS reports after 5-Minute Bout of Eccentric Exercise
DOMS pre
12
hrs
Placebo Mean 6.0
SD 1.6

Groups

Alkaline
Mean 4.5
Creatine
SD 1.9
Mg
Creatine Mean 5.0
Chelate
SD

2.9

60
hrs
5.0
2.2

DOMS
post
12 24 36
48
60
hrs hrs hrs hrs hrs
4.7 4.8 4.7 4.3 3.5
1.5 0.8 1.9 2.7 1.9

24
hrs
5.2
1.9

36
hrs
6.4
1.1

48
hrs
5.6
1.8

72
hrs
3.6
2.3

72
hrs
2.7
1.2

6.1

6.1

5.3 3.9 2.9

3.5

3.8

4.2

3.8

3.3 2.5

1.6

1.9

2.2 1.9 2.0

2.0

1.8

2.2

2.6

2.5 1.9

5.9

5.8

6.4 5.0 3.5

3.2

3.8

4.2

3.9

2.9 2.3

2.6

2.7

2.3 2.6 2.3

1.6

2.5

1.8

1.6

1.5 1.6

Figure 1. Delayed Onset Muscle Soreness Pre-Supplementation
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Figure 2. Delayed Onset Muscle Soreness Post-Supplementation
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Figure 3. Creatine Effect on Delayed Onset Muscle Soreness
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Discussion
This study examined the effects of magnesium-creatine chelate, alkaline creatine
compound, and placebo supplementation on DOMS following a bout of eccentric muscle
action to better understand the effects of creatine and magnesium supplementation on
exercise-induced muscle soreness. DOMS improved in the creatine groups as demonstrated
by lower levels of perceived soreness during the three days post exercise after the
intervention period.
The perceived lower level of soreness compared to the pretest persisted in the alkaline
creatine subjects for 36 hours. The findings presented in this project are consistent with
results reported by Santos et al. (2003) who reported that creatine supplementation resulted in
significant attenuation of muscle inflammatory markers (CK, LDH, PGE2, and TNF-α)
following exhaustive long distance running when compared to controls. Bassit et al. (2008)
reported similar findings regarding marked reductions in TNF-α , INFα, IL-1β, and PGE2
following half-ironman competition.
Conversely, in 2001 and again in 2007, Rawson et al. found creatine supplementation
was ineffective compared to controls, with both treatments resulting in equally significant
increases in inflammatory markers (CK and LDH) following high intensity eccentric muscle
action of the elbow flexors (2001) and hypoxic exercise via intensive leg squat exercise
protocol (2007). Interestingly, compared to the four-week supplementation time utilized in
this project, Bassit et al. (2008), Rawson et al. (2007), Santos et al. (2003) and Rawson
(2001) each utilized five-day loading doses of creatine, suggesting that a greater duration of
supplementation may be a better regime for attenuation of DOMS.
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Magnesium-creatine chelate subjects experienced reduced soreness enduring for 60
hours post exercise. While the effects of magnesium-creatine chelate supplementation did not
result in significantly improved DOMS compared to that of the alkaline creatine group,
research shows magnesium to have a positive effect on many inflammatory markers such as
C-reactive protein (Hata, et al., 2013) and TNF-α (Roman, Desai, Rochelson, Gupta, Solanki
et al., 2013). Additionally, research has shown magnesium is inversely related to more
general systemic inflammation (Song et al., 2005).

Summary
Alkaline creatine and magnesium-creatine chelate supplementation leads to
improvements in DOMS following a five-minute bout of high-intensity eccentric muscle
action after a four-week training period. The four-week supplementation time utilized in this
study was greater than that of many other research studies, which utilized only five-days of
creatine loading. Supplementation periods longer than four weeks may be necessary to elicit
positive effects on DOMS.
Magnesium and creatine are both known anti-inflammatory agents and active buffers
in the human body. These properties combined make creatine and magnesium especially
relevant for DOMS intervention considering inflammation is a characteristic of exerciseinduced DOMS and energy production may produce acidic conditions. While the role and
specific impact of creatine and magnesium supplementation is not clear, the antiinflammatory properties of both supplements should inspire new research to better
understand their impact on DOMS.
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Chapter V
Summary, Conclusions, and Reconditions
Summary
Eccentric exercise protocols are superior for generating more efficient gains in
strength, power and hypertrophy and improving activities of daily living (Kaminiski et al.;
LaStayo et al., 2003; Tesch et al., 2008). While the mechanism of eccentric muscle action
remains unclear, it is different than that of concentric muscle action as indicated by greater
efficiency of force generation (Ryschon et al., 1997). Delayed onset muscle soreness
(DOMS) is a well-known consequence of eccentric muscle action, the significance of which
may prevent individuals from reaping the benefits of eccentric training (Clarkson et al., 1986;
Newham et al., 1983; Rawson et al., 2001; Rawson et al., 2007).
Researchers have examined many interventions, including massage, hydrotherapy,
nutritional supplements and various exercise prescription protocols to ameliorate the effects
of DOMS (Best et al., 2008; Henschke et al., 2011; Vaile et al., 2008). None of these
interventions have proven reliably effective at DOMS reduction. However, creatine and
magnesium supplementation may be the most promising intervention for DOMS due to their
role in ATP generation and buffering as well as possible positive effects on inflammatory
markers (Bassit et al., 2008; Greenhaff et al., 1994; Parkhouse & McKenzie, 1984; Santos et
al., 2004). Through better understanding of the effects of creatine and magnesium
supplementation on DOMS, more informed decisions can be made regarding exercise and
supplement protocol.
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Conclusion
DOMS improved in the alkaline creatine and magnesium-creatine chelate groups as
demonstrated by lower levels of perceived soreness during the three days post exercise.
Compared to the pretest, the perceived lower level of soreness persisted in the alkaline
creatine subjects for 36 hours and endured for 60 hours in the magnesium-creatine chelate
group. Therefore, supplementation for 4 weeks may elicit more positive benefits compared to
shorter supplementation periods predominantly utilized in other research studies which were
inconsistent whether creatine attenuated DOMS.
Recommendations
Based on the findings of this study, the following are recommendations for future
research:
1. Conduct the same study with a larger sample population to protect against
attrition and outliers. This study experienced a high degree of attrition
which may have affected the results.
2. Conduct the same study with a different age group, specifically older
adults, to better understand the interaction between supplementation and
age.
3. Conduct the same study with a longer supplementation period to further
investigate if creatine groups would yield different results. It is common
practice by those who supplement with creatine to take it continuously.
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4. Conduct the same study utilizing blood analysis of inflammatory markers
in addition to DOMS reporting. This would provide additional data to
balance the subjective reporting of subjects which is inherently skewed.
5. The results of this study suggest that a period of creatine and magnesium-creatine
chelate supplementation may protect against DOMS following a bout of eccentric
exercise. The following are recommendations for application of finding:
1. Creatine and magnesium combined may be more effective than just
creatine. This requires further study.
2. The effects in this study show that four weeks of creatine may be a better
regimen than a loading dose in amelioration of DOMS used in other
studies (Rawson et al, 2003; Rawson et al., 2007)
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Appendix A
Human Subjects Proposal
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Effects of Creatine Magnesium Supplementation on Delayed Onset Muscle Soreness
Karla Landis
Human Subjects Activity Review Form
1. The Null Hypothesis states: Following high-intensity eccentric muscle action, there
will be no difference in DOMS due to supplementation of magnesium-creatine
chelate, alkaline creatine compound or placebo.
2. The potential benefits of this experiment include adding to a growing body of
literature regarding efficacy and nutritional safety of creatine supplementation.
Limited experiments focus on testing the effect of combining creatine with
magnesium or other alkalizing agents. With comparison between alkaline creatine
and magnesium-creatine chelated supplementation on body water and physical
performance attributes, the efficacy of this combination is tested with subsequent
meaning on the related changes for physical performance.
3. As a benefit for participation, the subjects will be introduced to a new form of
resistance training.
4. A) The subject population will be pooled from recreationally active participants who
volunteer either based on responses to fliers around Western Washington University
campus or from announcements made in Physical Education activity classes. The
investigator will then contact the subjects individually to explain the study, its
duration or expected time involvement and information regarding performance or
nutritive benefits to be expected from performing this experiment.
B) Thirty six (36) apparently healthy subjects will be chosen from this pool and
randomly assigned numerically to one of the three supplementation groups,
magmesium-creatine chelate, alkaline creatine, or placebo, maltodextrin, by a third
party. No additional compensation will be used.
5. Before testing, the participants will be informed of the testing procedures and will be
provided with the informed consent documents (See attached). During the
presentation of this study, the participant data will be assigned an identification
number in order to ensure confidentiality and anonymity. At no point will an
individual’s identifiable data be released to public sources.
Methods and Procedures
Description of the Study Population
The study population consisted of thirty-six apparently healthy, recreationally active
participants. Subjects were chosen randomly based on their volunteer responses to
brochures and flyers posted around Western Washington University (WWU) campus
and solicited from beginning weight training and conditioning classes. Prerequisite to
participation, each subject received an informed consent form previously approved by
the institution’s Human Subjects Committee, in accordance with the National
Institutes of Health guidelines. Subjects who had supplemented creatine or
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magnesium in their habitual diet within the 60 days prior to orientation or any who
were suffering from any kidney, liver, or endocrine disease or any disorder that might
affect normal cellular levels of Cr or fluid balance (or both) were excluded. The
medical history questionnaire filtered any subjects taking any substance classified as
a diuretic other than caffeine in their habitual diet. Subjects were instructed to keep
exercise regimens consistent throughout the study.
Design of the Study
This study followed a double blind, three group, format analyzed for a 4-week testing
period. These three groups consisted of an alkaline creatine group, a magnesiumcreatine chelate group, and a placebo group. Comparisons were made from baseline,
between and within groups for delayed muscle soreness [DOMS] after eccentric
exercise. Testing procedures were conducted at the same time of day to avoid
confounding errors.
Procedures and Instrumentation:
During baseline and posttest data collection, DOMS assessed by a 10-point scale after
a 5-minute lower body eccentric exercise bout. These measures are repeated at the
end of the study.
Supplementation:
Supplementation was given orally and all capsules provided by the manufacturer
appeared identical. Subjects were randomly assigned to groups (magnesium-creatine
chelate, alkaline creatine, placebo), and these were administered in a double blind
fashion. Subjects were given 5-g creatine equivalent per day in four equal doses or
placebo, maltodextrin. The magnesium was equivalent to 400 mg per day, a dose that
has previously been well tolerated in studies done in our laboratory. The alkalizing
agent in the other condition was soda ash. Subjects were instructed to take the
supplement with 16 oz (0.47 L) of liquid. The treatment period was four weeks to
allow for tissue saturation.
Exercise Protocols:
Subjects completed a 5-minute lower body eccentric exercise bout on a PreCor
exercise machine designed for eccentric muscle activity. Subjects were asked to rate
any DOMS at 12, 24, 48, and 72 hours after the exercise bout.
Data Analysis:
Descriptive statistics, means and standard deviations were calculated. Data were
analyzed using a repeated-measures ANOVA at an alpha level of 0.05. Data analysis
was done with Microsoft Excel 2007 and SPSS software version 11 (Chicago, IL).

6. All the testing was performed on a unilateral hip and knee extensor device developed
to elicit eccentric muscle actions. A similar device was used by LaStayo et al. (2003)
to examine eccentric muscle actions. The device was an eccentric ergometer which
was powered by a three horse power motor the drives the pedals, backward. An
eccentric muscle action was elicited by the subjects resisting the devices rotation. A
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similar device was constructed which consisted of eccentric ergometer was employed
by Evans et al. (1986). Rodenburg, Bar, and Boer (1993) used a device that had
similar applications but was used for the elbow flexor muscles. The subjects sat in a
chair with their chest against a support. The arm was also placed on a support in line
with the shoulder. A rope with weight was attached to the wrist via a pulley system.
Subjects resisted the weight using their elbow flexor muscle while it was being
lowered. This elicited a muscle action while muscle was being lengthened.
7. Control for this experiment consists of a placebo group ingesting a simple sugar,
maltodextrin, and given the same body composition and strength assessments as the
two creatine magnesium treatment groups. Eccentric muscle action is known to elicit
delayed onset muscle soreness therefore the eccentric ergometer is an appropriate
instrument.
8. Kurosawa, Hamaoka, Katsumura, Kuwamori, Kimura, Sako, & Chance (2003)
examined 25 healthy males using a handgrip dynamometer performed for a single 10
second maximal grip exercise. These subjects were measured pre and post
supplementation with either a 30 gram creatine monohydrate or placebo dosage each
day for 14 days. The subjects’ forearm muscles were evaluated by 31-phosphorus
magnetic resonance spectroscopy. The results indicate an increase in total anaerobic
ATP synthesis during the 10 second hand grip exercise after creatine supplementation
which positively correlated with the increase in ATP synthesis through PCr
hydrolysis (Kurosawa, Hamaoka, Katsumura, Kuwamori, Kimura, Sako, & Chance,
2003). Creatine supplementation produced a 15.1 +/- 3.8% increase in mean power
output during hand grip exercise. It is strongly indicated that an improvement in
performance was associated with the increased PCr availability for the synthesis of
ATP (Kurosawa, Hamaoka, Katsumura, Kuwamori, Kimura, Sako, & Chance, 2003).
Brilla and Haley (1992) studied the effects of magnesium supplementation on
strength training in humans. Their study investigated the effects of dietary magnesium
on strength development during a double-blind, 7-week strength training program in
26 untrained subjects aged 18 to 30 years old. Three-day diet records were analyzed
and Mg content was calculated. Body composition was assessed using BIA. The BIA
results demonstrate that although the Mg group reduced fat percentage while the
control group increased in fat percentage, these changes were not statistically
significant. Pre and post quadriceps torque was also measured; yet, unlike body fat,
the results indicated a significant (p < .05) increase in absolute torque for the Mg
supplementing group (Brilla & Haley, 1992).
9. As with any exercise, the possibilities of muscle fatigue or muscle injury can not be
entirely avoided. Supplementation with creatine can also cause some mild
discomforts that may occur in some subjects, including: dehydration, muscle cramps,
flatulence, and gastrointestinal distress. Dehydration and muscle cramping can be
typical effects of supplementation with creatine but can be decreased by assuring
proper hydration. Magnesium toxicity is rare and mostly affects people with kidney
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disease. However, this is not a concern for healthy people. All proper procedures
will be taken to reduce the risk of exercise-induced injuries including proper warm-up
and cool down activities.
10. In an effort to minimize risks and to limit side effects, a low dose short-term creatine
supplementation is used. Subjects who had supplemented creatine or magnesium in
their habitual diet within the 60 days prior to orientation or any who were suffering
from any kidney, liver, or endocrine disease or any disorder that might affect normal
cellular levels of creatine or fluid balance (or both) were excluded. The medical
history questionnaire filtered any subjects taking any substance classified as a diuretic
other than caffeine in their habitual diet.
All proper procedures, including a five-minute warm up and cool down provided by
the investigator, will be taken to reduce the risk of exercise-induced injuries.
11. Subjects identifiable information will be undisclosed during the study. During the
presentation of this study, the participant data will be assigned an identification
number in order to ensure confidentiality and anonymity. At no point will an
individual’s identifiable data be released to public sources. Subjects will be given
personal composition and strength measures only upon experiment completion or
termination. All data will be maintained electronically and hard copy in a cabinet in a
locked room.
12. N/A
13. N/A
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Appendix B
Informed Consent
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INFORMED CONSENT STATEMENT
Western Washington University
Physical Education, Health and Recreation Department
Title: Effect of Creatine Magnesium Supplementation on Delayed Onset Muscle Soreness
Print Name:

Karla Landis

The purpose of this study is to establish whether a low dose creatine compound, in
two different forms, supplemented for 28 days would show improved physical performance.
This study will contribute to the current literature on the possible benefits of creatine
supplementation for sport performance and the time course in which these benefits may be
achieved. This study will also investigate changes in body water. The benefit of this research
is that the subjects may develop increased strength and power allowing them to see improved
performance.
All participants will be required to take a supplement of magnesium-creatine chelate,
alkaline creatine, or placebo, a sugar capsule of maltodextrin for 28 days. Each participant
will complete tests pre and post supplementation. The tests include: 3-day dietary analysis
and 3-day physical activity log; body water and percent fat by bioelectrical impedance
analysis (BIA); neuromuscular function including strength and fatigue, anaerobic power, and
delayed onset muscle soreness [DOMS] after a 5-minute eccentric activity. They will be
collected pre-post each treatment phase. The testing consists of the orientation to equipment,
initial baseline testing and supplement distribution. Before beginning the program you will
be required to fill out a health history questionnaire. If you have any medical or physical
limitations, or have any renal disorders, you may not be eligible to participate in this study.
The baseline data will be collected the first week of the study and again during the
last week of the study. A familiarization session will take place prior to the initial testing to
establish measurements necessary for the testing procedures. The familiarization session will
last approximately 30 minutes and will be conducted in the Physiology Lab (CV 210) and
Biomechanics Lab (CV 146). The testing procedures after baseline and familiarization will
last approximately 30-45 minutes.
During the familiarization session your weight and height will be measured on a
balance beam scale and stadiometer. At this time you are instructed to complete the 3-day
diet record and 3-day activity log which will be returned on the day of testing.
Each testing session will consist of:
•
•
	
  

A 5-minute eccentric muscle test where a force is resisted at low velocity. Subsequent
emails will be sent by the subject to the investigator at 12, 24, 48, and 72 hours after
the test about any delayed onset muscle soreness [DOMS].
Total testing is expected to last approximately 20-30 minutes.
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Data will be used to quantify any differences between the results during each of the
testing periods.
Mild discomforts associated with exercise include: muscle fatigue, muscle soreness, or
muscle strain. Supplementation with creatine can also cause some mild discomforts that may
occur in some subjects, including: dehydration, flatulence, and gastrointestinal distress.
Dehydration can be typical effects of supplementation with creatine but can be decreased by
assuring proper hydration. Magnesium toxicity is rare and mostly affects people with kidney
disease. However, this is not a concern for most healthy people. Occasionally, people may
experience loose stools if they take a large dose of magnesium at one time. The
supplementation in this study separates the doses into morning and evening to avoid this
potential side effect. All proper procedures will be taken to reduce the risk of exerciseinduced injuries including proper recovery, warm-up, and cool down activities. Possible
benefits that some subjects may see resulting from participation in this study include: short
term gains in strength, power, muscle torque, increase in total body water and an increase in
exercise performance.
All subjects will be assigned a reference number to assure that all records will be kept
confidential. Data for each individual from each testing session will not be shared with other
subjects. Data will be collected on computer and kept in separate files that will be accessed
only by reference number.
Subject questions and concerns will be initially addressed during the orientation session
and subjects should feel free to ask questions and voice concerns as the study progresses.
Your participation in this study is greatly appreciated. This participation is voluntary and
you may withdraw yourself from participation at any time.
If you have any questions or comments during the course of the study please contact
Karla Landis directly at 206-849-0521, karla.landis@wwu.edu. I will answer any questions
you may have concerning the procedures. If you have any questions about your participation
or you rights as a research participant, you can contact Geri Walker, WWU Human
Protections Administrator, (360) 650-3220, geri.walker@wwu.edu.
Investigators: Lorrie Brilla, Kathy Knutzen, Brandi Row, and Karla Landis
I have read and understand the procedures for the study described above. I am aware of the
potential risks and I agree to participate as a subject in the study described above. I
understand that I may withdraw from participation at any time during the course of the
investigation.

	
  

Subject Signature:

Date:

Witness Signature:

Date:
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Appendix C
Visual Analog Scale
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Perceived Muscle Soreness (Clarkson et al., 1986).
Rate the general soreness of entire knee and hip extensor muscle groups when moving or
using the muscle.
.
1 (normal) – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 (very, very sore)
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Appendix D
Subject Data
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Subject Data
Creatine Pre-Testing DOMS
Results
12 24 36 48 60 72
Number P.O.C. hrs hrs hrs hrs hrs hrs
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Creatine Post-Testing
DOMS Results
12 24 36 48 60
hrs hrs hrs hrs hrs
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